Compare PRME & GMTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRME | GMTL |
|---|---|---|
| Founded | 2019 | 2021 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 666.1M | 582.1M |
| IPO Year | 2022 | 2026 |
| Metric | PRME | GMTL |
|---|---|---|
| Price | $2.84 | $17.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | $7.56 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 2.2M | 236.7K |
| Earning Date | 05-08-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.18 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,632,000.00 | N/A |
| Revenue This Year | $7.06 | N/A |
| Revenue Next Year | $47.01 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 55.28 | N/A |
| 52 Week Low | $1.11 | $12.75 |
| 52 Week High | $6.94 | $22.21 |
| Indicator | PRME | GMTL |
|---|---|---|
| Relative Strength Index (RSI) | 33.53 | 53.93 |
| Support Level | N/A | $12.75 |
| Resistance Level | $3.97 | $21.27 |
| Average True Range (ATR) | 0.24 | 1.69 |
| MACD | -0.06 | 0.18 |
| Stochastic Oscillator | 16.94 | 95.91 |
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.